Onychomycosis-Tinea-Unguium-Drug-Sales-Market-Report-2017
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1.2 Classification of <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> by Product Category 2<br />
1.2.1 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> by Types 2<br />
1.2.2 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Sales</strong> <strong>Market</strong> Share (%) by Types in 2016 2<br />
1.2.3 Oral 3<br />
1.2.4 External 3<br />
1.3 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> by Applications/End Users 4<br />
1.3.1 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> by Applications/End Users 4<br />
1.3.2 Age under 18 5<br />
1.3.3 Age 18-50 5<br />
1.3.4 Age above 50 6<br />
1.4 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> by Regions 7<br />
1.4.1 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Status and Prospect (2012-2022) 7<br />
1.4.2 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Status and Prospect (2012-2022) 8<br />
1.4.3 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Status and Prospect (2012-2022) 9<br />
1.4.4 Japan <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Status and Prospect (2012-2022) 10<br />
1.5 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue and Growth Rate (2012-2022) 11<br />
2 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Competition by Players, Type and Application 12<br />
2.1 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> Competition by Players 12<br />
2.2 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Sales</strong> and Revenue by Type 14<br />
2.3 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Sales</strong> and Revenue by Regions 17<br />
2.4 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Sales</strong> by Application 20<br />
3 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> (<strong>Sales</strong>, Revenue and Price) 23<br />
3.1 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (2012-<strong>2017</strong>) 23<br />
3.2 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Players 23
Change language